Pharmacy Search
Vertice Login
Menu
close

Transforming the workers’ compensation pharmacy and ancillary benefits management experience

Powered by state-of-the-art technology
Supported by human-centered service
Informed by industry expertise
Inspired by a commitment to care
blog

5 Tips to Help Workers’ Comp Payers Optimize IT Resources

The insurance sector is experiencing an IT talent shortage. How can workers’ comp payers optimize the IT resources they already have?
Read More
rxinformer

Things Change: The Growing Diversity of Pharmacy Cost Drivers

Smaller, more niche drug trends across different populations and geographies
Read More
INDUSTRY SURVEY

2023 Industry Insights Survey Report

We surveyed 500+ workers’ comp professionals on the biggest industry disruptors and priorities
Read More

Featured Videos

1 2

Personalize my experience

Make selections below to see articles and information related to your role and interests.

  • I am a

  • I'm interested in


Giving Notice: How Workforce Attrition Impacts Workers’ Comp

Millions of workers are changing occupations, leading to ripple effects for comp.

Summer 2022


FDA Approves Fleqsuvy for Spasticity

A new muscle relaxant for the treatment of spasticity, including from spinal cord injuries.

Mar 2022


2022 Workers’ Comp Industry Insights Survey Report

Nearly 500 stakeholders share their thoughts on industry challenges and priorities.

Mar 2022


Changing Workforce, Claims Automation and Tech Connectivity Among Top Priorities in 2022 Industry Survey

The priorities and challenges revealed in our 2022 Workers’ Compensation Industry Insights Survey Report reflect an industry focused on moving forward.

Mar 2022


CDC to Update Opioid Guideline

Proposed changes are open to public comment until April 11th.

Mar 2022


First Responder PTSD Bills Return to the Forefront

After a drop in activity due to the pandemic, five states are now considering legislation.

Mar 2022


Five Things to Know About Workers’ Compensation Pharmacy Services

Healthe’s VP of Industry and State Affairs, Sandy Shtab, joined an educational webinar from IAIABC.

Mar 2022


State of the States

A roundup of regulatory activity around the country

Summer 2022


FDA Issues Warning for Dental Problems with Dissolvable Buprenorphine Products

Buprenorphine is an opioid used to treat pain, as well as opioid-use disorder.

Feb 2022


Classification Complications: Will Gig Workers Enter the Workers’ Comp Market?

Legislation could potentially reclassify gig workers as employees entitled to workers’ comp.

Feb 2022


FDA Fully Approves Moderna Vaccine & Expands Veklury’s Treatment Range

Drug advancements surrounding the prevention and treatment of COVID-19.

Feb 2022


Marijuana: States Move Forward Medically and Recreationally, But Oppose Reimbursement in Comp

Since the start of 2022, at least 10 states are considering some form of marijuana legislation.

Feb 2022


Claims Adjusters Are the Future Leaders of Workers’ Comp: How Can We Nurture Their Success?

Healthe’s Director of Product Management talks to Risk & Insurance on how to attract and retain talent in the workers’ comp industry.

Feb 2022


FDA Approves Yusimry as a Biosimilar to Humira

This autoimmune drug was approved for various arthritic and autoimmune diseases.

Jan 2022


The Top Priorities of the Workers’ Comp Industry for Future Resiliency

The initial results from a collaborative survey between Healthe and Risk & Insurance.®

Jan 2022


Additional Vaccine Candidate Performs Well in Clinical Trials

Phase 3 trials for NVX-CoV2373 across 30,000 people found this vaccine candidate to be safe and effective for the prevention of COVID-19.

Jan 2022


CDC Updates Isolation and Quarantine Period for COVID-19

New five-day rules are recommended, with variation depending upon vaccination status.

Jan 2022


The Great Resignation Continues to Impact Workforce Dynamics

The Bureau of Labor Statistics reports that 4.5 million employees quit their jobs in November 2021.

Jan 2022


4 Ways to Manage Medical Supply Chain Disruption in Workers’ Comp

Healthe’s SVP of Product Strategy and Innovation, Kristine Kennedy, discusses this topic with Risk & Insurance magazine.

Jan 2022


COVID-19 Pill Approval and More Updates

Molnupiravir, Paxlovid, and AZD7442 have shown promise in Phase 3 trials.

Dec 2021


The Long Haul: Chronic Health Complications of COVID-19

Those previously infected by the virus may face long-term health complications.

Dec 2021


Can Virtual Reality Help with Pain Management?

A new study found that VR sessions averaged a 40% reduction in pain and decreased opioid use.

Dec 2021


Federal Judges Try to Block Vaccine Mandates

Rulings from U.S. District Courts have impeded vaccine requirements among certain workers.

Dec 2021


FDA Authorizes COVID-19 Booster Shots for All Adults

All adults may now receive a booster shot of any COVID-19 vaccine.

Dec 2021


FDA Approves Zimhi and Seglentis

A new naloxone drug and a new opioid-NSAID combination.

Nov 2021


Sickness and Society: The Future of Infectious Disease in the Workplace

Strategies for a safer, healthier workforce amid COVID-19 and beyond.

Nov 2021


FDA Authorizes Booster Shots for Moderna and J&J Vaccines

All COVID-19 vaccines now have emergency use authorization for a booster dose.

Nov 2021


Cannabis in the Workplace on the Rise

One-third of employees have witnessed cannabis use during work hours.

Nov 2021


Texas Telemedicine Report

Pre-pandemic, 951 claims received telemedicine, jumping to 21,000 during the pandemic.

Nov 2021


Healthesystems at WCI & SAWCA

Visit Healthe at WCI booth #913! Plus, a recap of a SAWCA roundtable, featuring Sandy Shtab.

Nov 2021

1 2 3 4 5 6 7 8 9 … 16 17 18 19 20
lockenvelopephone-handsetmagnifiermenuarrow-rightcross-circle